Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-
Fiche publication
Date publication
septembre 2021
Journal
Journal of cancer research and clinical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ALBUISSON Eliane, Pr RUBIO Marie Thérèse , Dr POCHON Cécile
Tous les auteurs :
Pochon C, Detrait M, Dalle JH, Michel G, Dhédin N, Chalandon Y, Brissot E, Forcade E, Sirvent A, Izzadifar-Legrand F, Michallet M, Renard C, Yakoub-Agha I, Gonzales F, Bay JO, Kanold J, Cornillon J, Bulabois CE, Angoso M, Nguyen S, Balza M, Chevallier P, Rialland F, Bazarbachi A, Beguin Y, Huynh A, Ménard AL, Schneider P, Neven B, Paillard C, Raus N, Albuisson E, Remen T, Rubio MT
Lien Pubmed
Résumé
There are currently few data on the outcome of acute myeloid leukemia (AML) in adolescents after allogeneic HSCT. The aim of this study is to describe the outcome and its specific risk factors for children, adolescents and young adults after a first allogeneic HSCT for AML.
Mots clés
Acute GVHD, Acute myeloblastic leukemia, Adolescent and post-adolescent patients, Allogeneic hematopoietic stem cell transplantation, Children, Chronic GVHD, Outcome, Young adults
Référence
J Cancer Res Clin Oncol. 2021 Sep 4;: